Streetbeat News

Price Targets

LAZ

Morgan Stanley analyst Ryan Kenny has maintained an Overweight rating on Lazard (NYSE:LAZ) but lowered the price target from $42 to $41.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 2:18 pm

KDP

Bernstein has maintained an Outperform rating on Keurig Dr Pepper but lowered its price target from $40 to $37. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 2:10 pm

PLUG

Susquehanna analyst Biju Perincheril maintains a positive outlook on Plug Power (NASDAQ:PLUG), but has lowered the price target from $14 to $13.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 1:42 pm

ASML

Susquehanna analyst Mehdi Hosseini has maintained a positive rating on ASML Holding (NASDAQ:ASML) but lowered the price target from $850 to $810.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 1:40 pm

TSX:TOY

Stifel analyst Martin Landry has maintained a 'Buy' rating on Spin Master and raised the price target from C$50 to C$54.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 1:35 pm

BAH

Stifel analyst Bert Subin has maintained a 'Buy' rating on Booz Allen Hamilton (NYSE:BAH) and raised the price target from $127 to $140.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 1:27 pm

BILI

Goldman Sachs analyst Lincoln Kong has maintained a Neutral rating on Bilibili (NASDAQ:BILI) and lowered the price target from $19.6 to $17.4.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 1:25 pm

ACMR

Goldman Sachs analyst Allen Chang maintains a Neutral rating on ACM Research (NASDAQ:ACMR) and raises the price target from $16.2 to $18.2.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 1:24 pm

VOD

Goldman Sachs analyst Andrew Lee maintains a Buy rating on Vodafone Group (NASDAQ:VOD) and raises the price target from $13.7 to $14.45.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 1:22 pm

LBPH

Wedbush analyst Laura Chico has reiterated an Outperform rating on Longboard Pharmaceuticals (NASDAQ:LBPH) and maintained a price target of $11.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 1:16 pm